Fierce Biotech News & Reports
WEB3 days ago · The Fierce 50 of 2024. Shining a spotlight on the people and companies who are driving meaningful change in healthcare, pharma and biotech. Ayla Ellison Sep 9, 2024 5:00am. Medtech News.
Grail delivers final study results showing its blood test's accuracy in ...
WEBJun 25, 2021 · The final results from a Grail study of its cancer-tracing blood test found it was accurate at detecting a range of different tumors at early stages—especially those more likely to be lethal and ha
FDA clears first non-drug fibromyalgia treatment - Fierce Biotech
WEBMay 19, 2022 · The Quell device received an initial 510(k) clearance from the FDA in 2014, when it was indicated as an over-the-counter treatment for chronic pain—without a specific focus on fibromyalgia ...
New AI drug discovery powerhouse Xaira rises with $1B in funding
WEBApr 24, 2024 · The company emerged Tuesday with $1 billion in committed funding—that’s billion with a B—incubated by Arch Venture Partners and Foresite Labs with none other than Marc Tessier-Lavigne, Ph.D ...
Grail launches long-awaited Galleri blood test, its groundbreaking ...
WEBJun 7, 2021 · Grail took a major step forward in its quest to deliver a single blood test capable of detecting the presence of multiple cancers with the long-awaited launch of its Galleri diagnostic.
Bristol Myers pays $800M upfront for antibody-drug conjugate
WEBDec 12, 2023 · Bristol Myers Squibb has filled the antibody-drug conjugate (ADC) shaped hole in its pipeline by following the increasingly well-trodden path to China, handing SystImmune $800 million upfront for ...
Scribe Therapeutics snags $100M for engineered CRISPR tech, …
WEBMar 31, 2021 · Scribe Therapeutics is adding another $100 million to its coffers six months after unveiling a $20 million series A and a partnership with Biogen to work on gene editing treatments for amyotrophic ...
Blood storage tech developer Hemanext adds $15M to VC stores …
WEBSep 30, 2021 · The Hemanext One system comprises two components. The blood cells are first placed in an oxygen reduction bag. Its double-walled mechanism includes a sorbent between the inner and outer walls to ...
Roivant gets $200M for major push into protein degradation
WEBDec 7, 2020 · Roivant Sciences has secured $200 million to advance its protein degradation ambitions. Armed with the money, Roivant CEO Vivek Ramaswamy plans to use the VantAI platform to spawn multiple new ...
Vivace snares $30M to push Hippo-targeting drugs into the clinic
WEBDec 16, 2020 · Three years after coming of out stealth, Vivace Therapeutics has raised another $30 million to pursue drugs targeting the Hippo-YAP pathway. The funding, drawn from Boxer Capital, RA Capital ...
Skip to content